 | • レポートコード：GIR-105X03769 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、慢性疼痛治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。慢性疼痛治療の種類別市場規模（医薬品、デバイス）、用途別市場規模（病院、診療所、老人ホーム、研究センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・慢性疼痛治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly and Company、GlaxoSmithKline、Pfizer、Medtronic、Abbott Laboratories、Boston Scientific Corporation、Novartis AG、Johnson & Johnson、AstraZeneca PLC、Bristol-Myers Squibb、Becton, Dickinson and Company、Sanofi ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：医薬品、デバイス ・用途別分析2016年-2026年：病院、診療所、老人ホーム、研究センター ・慢性疼痛治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・慢性疼痛治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・慢性疼痛治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・慢性疼痛治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・慢性疼痛治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chronic Pain Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chronic Pain Treatment size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Chronic Pain Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Chronic Pain Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drugs
Devices
Market segment by Application can be divided into
Hospitals
Clinics
Nursing Homes
Research Centers
The key market players for global Chronic Pain Treatment market are listed below:
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Chronic Pain Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chronic Pain Treatment, with price, sales, revenue and global market share of Chronic Pain Treatment from 2019 to 2021.
Chapter 3, the Chronic Pain Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chronic Pain Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Chronic Pain Treatment market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Chronic Pain Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Chronic Pain Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chronic Pain Treatment Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Drugs
1.2.3 Devices
1.3 Market Analysis by Application
1.3.1 Overview: Global Chronic Pain Treatment Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Nursing Homes
1.3.5 Research Centers
1.4 Global Chronic Pain Treatment Market Size & Forecast
1.4.1 Global Chronic Pain Treatment Sales in Value (2016-2026))
1.4.2 Global Chronic Pain Treatment Sales in Volume (2016-2026)
1.4.3 Global Chronic Pain Treatment Price by Type (2016-2026) & (USD/Unit)
1.5 Global Chronic Pain Treatment Production Capacity Analysis
1.5.1 Global Chronic Pain Treatment Total Production Capacity (2016-2026)
1.5.2 Global Chronic Pain Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chronic Pain Treatment Market Drivers
1.6.2 Chronic Pain Treatment Market Restraints
1.6.3 Chronic Pain Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business
2.1.3 Eli Lilly and Company Chronic Pain Treatment Product and Services
2.1.4 Eli Lilly and Company Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Chronic Pain Treatment Product and Services
2.2.4 GlaxoSmithKline Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Chronic Pain Treatment Product and Services
2.3.4 Pfizer Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business
2.4.3 Medtronic Chronic Pain Treatment Product and Services
2.4.4 Medtronic Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Abbott Laboratories
2.5.1 Abbott Laboratories Details
2.5.2 Abbott Laboratories Major Business
2.5.3 Abbott Laboratories Chronic Pain Treatment Product and Services
2.5.4 Abbott Laboratories Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Boston Scientific Corporation
2.6.1 Boston Scientific Corporation Details
2.6.2 Boston Scientific Corporation Major Business
2.6.3 Boston Scientific Corporation Chronic Pain Treatment Product and Services
2.6.4 Boston Scientific Corporation Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business
2.7.3 Novartis AG Chronic Pain Treatment Product and Services
2.7.4 Novartis AG Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Chronic Pain Treatment Product and Services
2.8.4 Johnson & Johnson Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 AstraZeneca PLC
2.9.1 AstraZeneca PLC Details
2.9.2 AstraZeneca PLC Major Business
2.9.3 AstraZeneca PLC Chronic Pain Treatment Product and Services
2.9.4 AstraZeneca PLC Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Bristol-Myers Squibb
2.10.1 Bristol-Myers Squibb Details
2.10.2 Bristol-Myers Squibb Major Business
2.10.3 Bristol-Myers Squibb Chronic Pain Treatment Product and Services
2.10.4 Bristol-Myers Squibb Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Becton, Dickinson and Company
2.11.1 Becton, Dickinson and Company Details
2.11.2 Becton, Dickinson and Company Major Business
2.11.3 Becton, Dickinson and Company Chronic Pain Treatment Product and Services
2.11.4 Becton, Dickinson and Company Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Sanofi
2.12.1 Sanofi Details
2.12.2 Sanofi Major Business
2.12.3 Sanofi Chronic Pain Treatment Product and Services
2.12.4 Sanofi Chronic Pain Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Chronic Pain Treatment Sales by Manufacturer
3.1 Global Chronic Pain Treatment Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Chronic Pain Treatment Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Chronic Pain Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Chronic Pain Treatment Manufacturer Market Share
3.4.2 Top 6 Chronic Pain Treatment Manufacturer Market Share
3.5 Global Chronic Pain Treatment Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Chronic Pain Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chronic Pain Treatment Market Size by Region
4.1.1 Global Chronic Pain Treatment Sales in Volume by Region (2016-2026)
4.1.2 Global Chronic Pain Treatment Revenue by Region (2016-2026)
4.2 North America Chronic Pain Treatment Revenue (2016-2026)
4.3 Europe Chronic Pain Treatment Revenue (2016-2026)
4.4 Asia-Pacific Chronic Pain Treatment Revenue (2016-2026)
4.5 South America Chronic Pain Treatment Revenue (2016-2026)
4.6 Middle East and Africa Chronic Pain Treatment Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Chronic Pain Treatment Sales in Volume by Type (2016-2026)
5.2 Global Chronic Pain Treatment Revenue by Type (2016-2026)
5.3 Global Chronic Pain Treatment Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Chronic Pain Treatment Sales in Volume by Application (2016-2026)
6.2 Global Chronic Pain Treatment Revenue by Application (2016-2026)
6.3 Global Chronic Pain Treatment Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Chronic Pain Treatment Sales by Type (2016-2026)
7.2 North America Chronic Pain Treatment Sales by Application (2016-2026)
7.3 North America Chronic Pain Treatment Market Size by Country
7.3.1 North America Chronic Pain Treatment Sales in Volume by Country (2016-2026)
7.3.2 North America Chronic Pain Treatment Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Chronic Pain Treatment Sales by Type (2016-2026)
8.2 Europe Chronic Pain Treatment Sales by Application (2016-2026)
8.3 Europe Chronic Pain Treatment Market Size by Country
8.3.1 Europe Chronic Pain Treatment Sales in Volume by Country (2016-2026)
8.3.2 Europe Chronic Pain Treatment Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Chronic Pain Treatment Sales by Type (2016-2026)
9.2 Asia-Pacific Chronic Pain Treatment Sales by Application (2016-2026)
9.3 Asia-Pacific Chronic Pain Treatment Market Size by Region
9.3.1 Asia-Pacific Chronic Pain Treatment Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Chronic Pain Treatment Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Chronic Pain Treatment Sales by Type (2016-2026)
10.2 South America Chronic Pain Treatment Sales by Application (2016-2026)
10.3 South America Chronic Pain Treatment Market Size by Country
10.3.1 South America Chronic Pain Treatment Sales in Volume by Country (2016-2026)
10.3.2 South America Chronic Pain Treatment Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chronic Pain Treatment Sales by Type (2016-2026)
11.2 Middle East & Africa Chronic Pain Treatment Sales by Application (2016-2026)
11.3 Middle East & Africa Chronic Pain Treatment Market Size by Country
11.3.1 Middle East & Africa Chronic Pain Treatment Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Chronic Pain Treatment Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Chronic Pain Treatment Typical Distributors
12.3 Chronic Pain Treatment Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Chronic Pain Treatment Revenue by Type, (USD Million), 2021-2026
Table 2. Global Chronic Pain Treatment Revenue by Application, (USD Million), 2021-2026
Table 3. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 4. Eli Lilly and Company Major Business
Table 5. Eli Lilly and Company Chronic Pain Treatment Product and Services
Table 6. Eli Lilly and Company Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Chronic Pain Treatment Product and Services
Table 10. GlaxoSmithKline Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Chronic Pain Treatment Product and Services
Table 14. Pfizer Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Medtronic Basic Information, Manufacturing Base and Competitors
Table 16. Medtronic Major Business
Table 17. Medtronic Chronic Pain Treatment Product and Services
Table 18. Medtronic Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Abbott Laboratories Major Business
Table 21. Abbott Laboratories Chronic Pain Treatment Product and Services
Table 22. Abbott Laboratories Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 24. Boston Scientific Corporation Major Business
Table 25. Boston Scientific Corporation Chronic Pain Treatment Product and Services
Table 26. Boston Scientific Corporation Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 28. Novartis AG Major Business
Table 29. Novartis AG Chronic Pain Treatment Product and Services
Table 30. Novartis AG Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Major Business
Table 33. Johnson & Johnson Chronic Pain Treatment Product and Services
Table 34. Johnson & Johnson Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. AstraZeneca PLC Basic Information, Manufacturing Base and Competitors
Table 36. AstraZeneca PLC Major Business
Table 37. AstraZeneca PLC Chronic Pain Treatment Product and Services
Table 38. AstraZeneca PLC Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 40. Bristol-Myers Squibb Major Business
Table 41. Bristol-Myers Squibb Chronic Pain Treatment Product and Services
Table 42. Bristol-Myers Squibb Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 44. Becton, Dickinson and Company Major Business
Table 45. Becton, Dickinson and Company Chronic Pain Treatment Product and Services
Table 46. Becton, Dickinson and Company Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sanofi Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi Major Business
Table 49. Sanofi Chronic Pain Treatment Product and Services
Table 50. Sanofi Chronic Pain Treatment Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Chronic Pain Treatment Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Chronic Pain Treatment Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Chronic Pain Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Chronic Pain Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Chronic Pain Treatment Production Site of Key Manufacturer
Table 56. Chronic Pain Treatment New Entrant and Capacity Expansion Plans
Table 57. Chronic Pain Treatment Mergers & Acquisitions in the Past Five Years
Table 58. Global Chronic Pain Treatment Sales by Region (2016-2021e) & (K Units)
Table 59. Global Chronic Pain Treatment Sales by Region (2021-2026) & (K Units)
Table 60. Global Chronic Pain Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Chronic Pain Treatment Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Chronic Pain Treatment Sales by Type (2016-2021e) & (K Units)
Table 63. Global Chronic Pain Treatment Sales by Type (2021-2026) & (K Units)
Table 64. Global Chronic Pain Treatment Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Chronic Pain Treatment Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Chronic Pain Treatment Price by Type (2016-2021e) & (USD/Unit)
Table 67. Global Chronic Pain Treatment Price by Type (2021-2026) & (USD/Unit)
Table 68. Global Chronic Pain Treatment Sales by Application (2016-2021e) & (K Units)
Table 69. Global Chronic Pain Treatment Sales by Application (2021-2026) & (K Units)
Table 70. Global Chronic Pain Treatment Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Chronic Pain Treatment Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Chronic Pain Treatment Price by Application (2016-2021e) & (USD/Unit)
Table 73. Global Chronic Pain Treatment Price by Application (2021-2026) & (USD/Unit)
Table 74. North America Chronic Pain Treatment Sales by Country (2016-2021e) & (K Units)
Table 75. North America Chronic Pain Treatment Sales by Country (2021-2026) & (K Units)
Table 76. North America Chronic Pain Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Chronic Pain Treatment Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Chronic Pain Treatment Sales by Type (2016-2021e) & (K Units)
Table 79. North America Chronic Pain Treatment Sales by Type (2021-2026) & (K Units)
Table 80. North America Chronic Pain Treatment Sales by Application (2016-2021e) & (K Units)
Table 81. North America Chronic Pain Treatment Sales by Application (2021-2026) & (K Units)
Table 82. Europe Chronic Pain Treatment Sales by Country (2016-2021e) & (K Units)
Table 83. Europe Chronic Pain Treatment Sales by Country (2021-2026) & (K Units)
Table 84. Europe Chronic Pain Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Chronic Pain Treatment Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Chronic Pain Treatment Sales by Type (2016-2021e) & (K Units)
Table 87. Europe Chronic Pain Treatment Sales by Type (2021-2026) & (K Units)
Table 88. Europe Chronic Pain Treatment Sales by Application (2016-2021e) & (K Units)
Table 89. Europe Chronic Pain Treatment Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific Chronic Pain Treatment Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific Chronic Pain Treatment Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific Chronic Pain Treatment Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Chronic Pain Treatment Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Chronic Pain Treatment Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific Chronic Pain Treatment Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific Chronic Pain Treatment Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific Chronic Pain Treatment Sales by Application (2021-2026) & (K Units)
Table 98. South America Chronic Pain Treatment Sales by Country (2016-2021e) & (K Units)
Table 99. South America Chronic Pain Treatment Sales by Country (2021-2026) & (K Units)
Table 100. South America Chronic Pain Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Chronic Pain Treatment Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Chronic Pain Treatment Sales by Type (2016-2021e) & (K Units)
Table 103. South America Chronic Pain Treatment Sales by Type (2021-2026) & (K Units)
Table 104. South America Chronic Pain Treatment Sales by Application (2016-2021e) & (K Units)
Table 105. South America Chronic Pain Treatment Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa Chronic Pain Treatment Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa Chronic Pain Treatment Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa Chronic Pain Treatment Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Chronic Pain Treatment Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Chronic Pain Treatment Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa Chronic Pain Treatment Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa Chronic Pain Treatment Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa Chronic Pain Treatment Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Chronic Pain Treatment Typical Distributors
Table 117. Chronic Pain Treatment Typical Customers
List of Figures
Figure 1. Chronic Pain Treatment Picture
Figure 2. Global Chronic Pain Treatment Sales Market Share by Type in 2020
Figure 3. Drugs
Figure 4. Devices
Figure 5. Global Chronic Pain Treatment Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Nursing Homes
Figure 9. Research Centers
Figure 10. Global Chronic Pain Treatment Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Chronic Pain Treatment Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Chronic Pain Treatment Sales (2016-2026) & (K Units)
Figure 13. Global Chronic Pain Treatment Price by Type (2016-2026) & (USD/Unit)
Figure 14. Global Chronic Pain Treatment Production Capacity (2016-2026) & (K Units)
Figure 15. Global Chronic Pain Treatment Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Chronic Pain Treatment Market Drivers
Figure 17. Chronic Pain Treatment Market Restraints
Figure 18. Chronic Pain Treatment Market Trends
Figure 19. Global Chronic Pain Treatment Sales Market Share by Manufacturer in 2020
Figure 20. Global Chronic Pain Treatment Revenue Market Share by Manufacturer in 2020
Figure 21. Chronic Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Chronic Pain Treatment Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Chronic Pain Treatment Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Chronic Pain Treatment Sales Market Share by Region (2016-2026)
Figure 25. Global Chronic Pain Treatment Revenue Market Share by Region (2016-2026)
Figure 26. North America Chronic Pain Treatment Revenue (2016-2026) & (USD Million)
Figure 27. Europe Chronic Pain Treatment Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Chronic Pain Treatment Revenue (2016-2026) & (USD Million)
Figure 29. South America Chronic Pain Treatment Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Chronic Pain Treatment Revenue (2016-2026) & (USD Million)
Figure 31. Global Chronic Pain Treatment Sales Market Share by Type (2016-2026)
Figure 32. Global Chronic Pain Treatment Revenue Market Share by Type (2016-2026)
Figure 33. Global Chronic Pain Treatment Price by Type (2016-2026) & (USD/Unit)
Figure 34. Global Chronic Pain Treatment Sales Market Share by Application (2016-2026)
Figure 35. Global Chronic Pain Treatment Revenue Market Share by Application (2016-2026)
Figure 36. Global Chronic Pain Treatment Price by Application (2016-2026) & (USD/Unit)
Figure 37. North America Chronic Pain Treatment Sales Market Share by Type (2016-2026)
Figure 38. North America Chronic Pain Treatment Sales Market Share by Application (2016-2026)
Figure 39. North America Chronic Pain Treatment Sales Market Share by Country (2016-2026)
Figure 40. North America Chronic Pain Treatment Revenue Market Share by Country (2016-2026)
Figure 41. United States Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Chronic Pain Treatment Sales Market Share by Type (2016-2026)
Figure 45. Europe Chronic Pain Treatment Sales Market Share by Application (2016-2026)
Figure 46. Europe Chronic Pain Treatment Sales Market Share by Country (2016-2026)
Figure 47. Europe Chronic Pain Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Chronic Pain Treatment Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Chronic Pain Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Chronic Pain Treatment Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Chronic Pain Treatment Revenue Market Share by Region (2016-2026)
Figure 57. China Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Chronic Pain Treatment Sales Market Share by Type (2016-2026)
Figure 64. South America Chronic Pain Treatment Sales Market Share by Application (2016-2026)
Figure 65. South America Chronic Pain Treatment Sales Market Share by Country (2016-2026)
Figure 66. South America Chronic Pain Treatment Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Chronic Pain Treatment Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Chronic Pain Treatment Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Chronic Pain Treatment Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Chronic Pain Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Chronic Pain Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
世界の慢性気管支炎治療市場 2021：企業別、地域別、種類・用途別 The Chronic Bronchitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 世界の急性・慢性アレルギー性結膜炎治療市場 2021：企業別、地域別、種類・用途別 The Acute and Chronic Allergic Conjunctivitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 慢性閉塞性肺動脈の病気トリートメントの世界市場2018-2025 In 2018, the global Chronic Obstructive Pulmonary Disease Treatment market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Chro…
- 慢性閉塞性肺疾患の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
- 慢性腎疾患（CKD）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function. Scope of the Report: This report focuses on the Chronic Kidney Disease (CKD) Drugs in global market, especially in North America, Europe a…